Medical Patent Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Patents
Carrington Subsidiary DelSite Granted Growth Factor Stabilizer Patent By Korean Patent Office
April 11th, 2007
Carrington Laboratories, Inc. (NASDAQ:CARN) announced the Korean Patent Office has issued a Notice of Allowance for Korean Patent Application No. 10-2001-7000869 titled "Pectic Substance As A Growth Factor Stabilizer" relating to the Company's proprietary GelSite(R) polymer's ability to bind to and stabilize proteins and peptides. DelSite Biotechnologies, Inc., Carrington's wholly-owned subsidiary, is developing and commercializing GelSite(R) polymer as a controlled-release drug delivery technology for vaccines and therapeutics. The patent describes growth factor stabilization and delivery with this polymer. The claims of this patent are broadly applicable to any use of...
Source: Medical Patent Law Weekly (2007-04-11)
|
